Levofloxacin Olikla (Levofloxacin Hemihydrate)

Levofloxacin exerts its antibacterial effect by inhibiting the bacterial enzymes DNA gyrase (topoisomerase II) and topoisomerase IV. These enzymes are essential for DNA supercoiling, replication, and transcription. Blocking their activity prevents bacterial DNA synthesis, leading to rapid bacterial cell death.

The dosing regimen for Levofloxacin Olikla is determined by the prescribing clinician based on the severity of the infection, the patient’s age, and ocular condition. Healthcare professionals set the frequency and duration of eye‑drop administration according to current clinical guidelines.

Safety data for levofloxacin ophthalmic use in pregnancy and lactation are limited. The product should be used only if the potential therapeutic benefit justifies any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Levofloxacin belongs to the fluoroquinolone class, offering broad‑spectrum coverage and rapid bactericidal activity. Compared with older agents such as ciprofloxacin, levofloxacin often provides higher potency against resistant strains and requires less frequent dosing. However, choice of therapy should consider local resistance patterns and patient‑specific factors.

Levofloxacin Olikla should be stored at ambient temperature, preferably below 25 °C, in its original container. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations to maintain stability and efficacy.

The product is applied as an eye drop. The patient should wash hands, tilt the head back, pull down the lower eyelid, and instill the prescribed number of drops into the conjunctival sac. The eye should be closed gently for a few seconds to allow absorption, avoiding immediate blinking.

Serious adverse reactions include worsening of corneal ulcers, severe allergic responses such as swelling or rash around the eye, and rare systemic events like tendon rupture or QT‑interval prolongation. Patients should seek immediate medical attention if they experience any of these symptoms.

Levofloxacin Olikla is contraindicated in individuals with a known hypersensitivity to levofloxacin, other fluoroquinolones, or any component of the formulation. Caution is also advised for patients with a history of tendon disorders, significant cardiac arrhythmias, or severe ocular surface disease without specialist supervision.